Page last updated: 2024-09-05

ak 295 and Brain Injuries

ak 295 has been researched along with Brain Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartus, RT; Hayward, NJ; McIntosh, TK; Murai, H; Perri, BR; Saatman, KE; Smith, DH1
Bartus, RT; McIntosh, TK; Saatman, KE; Zhang, C1

Other Studies

2 other study(ies) available for ak 295 and Brain Injuries

ArticleYear
Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-16, Volume: 93, Issue:8

    Topics: Animals; Brain Injuries; Calpain; Cognition Disorders; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Male; Memory; Psychomotor Performance; Rats; Rats, Sprague-Dawley

1996
Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2000, Volume: 20, Issue:1

    Topics: Animals; Apoptosis; Behavior, Animal; Brain Injuries; Calpain; Cerebral Cortex; Cysteine Proteinase Inhibitors; Dipeptides; Male; Peptide Hydrolases; Rats; Rats, Sprague-Dawley; Spectrin

2000